BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17879916)

  • 1. Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients.
    Cervia JS; Wenz B; Ortolano GA
    Clin Infect Dis; 2007 Oct; 45(8):1008-13. PubMed ID: 17879916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.
    Smith D; Lu Q; Yuan S; Goldfinger D; Fernando LP; Ziman A
    Vox Sang; 2010 Jan; 98(1):29-36. PubMed ID: 19695013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte-reduced blood components: patient benefits and practical applications.
    Higgins VL
    Oncol Nurs Forum; 1996 May; 23(4):659-67. PubMed ID: 8735324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal leukocyte reduction of blood transfusions.
    Blumberg N; Heal JM
    Clin Infect Dis; 2007 Oct; 45(8):1014-5. PubMed ID: 17879917
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs.
    Lane TA
    Arch Pathol Lab Med; 1994 Apr; 118(4):392-404. PubMed ID: 8166589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood issues update: minimizing the risk of transfusion-associated HIV infection. American Hospital Association Technical Advisory Task Force on Blood Resources.
    Hosp Technol Ser; 1989 Aug; 8(21):1-14. PubMed ID: 10314380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion risks and limitations.
    Mercuriali F; Inghilleri G
    Minerva Anestesiol; 1999 May; 65(5):286-92. PubMed ID: 10389406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing emerging infectious threats to blood safety for the blood disorders community.
    Trimble SR; Parker CS; Grant AM; Soucie JM; Reyes N
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S468-74. PubMed ID: 20331945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen inactivation technology: cleansing the blood supply.
    Klein HG
    J Intern Med; 2005 Mar; 257(3):224-37. PubMed ID: 15715679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The need for thorough infection screening in donors of autologous blood].
    Heim MU; Mempel W
    Beitr Infusionsther; 1991; 28():313-6. PubMed ID: 1725645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious risks of blood transfusion.
    Uhl L
    Curr Hematol Rep; 2002 Nov; 1(2):156-62. PubMed ID: 12901138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of blood transfusion and their prevention.
    Sandler SG; Yu H; Rassai N
    Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion transmitted infectious diseases.
    Holland PV
    J Fla Med Assoc; 1993 Jan; 80(1):33-6. PubMed ID: 8436930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-transmitted bacterial infection: risks, sources and interventions.
    Wagner SJ
    Vox Sang; 2004 Apr; 86(3):157-63. PubMed ID: 15078249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-transmitted infections among multitransfused patients in Iran: a review.
    Rezvan H; Abolghassemi H; Kafiabad SA
    Transfus Med; 2007 Dec; 17(6):425-33. PubMed ID: 18067646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-transmitted infectious diseases.
    Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
    Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood safety.
    Chamberland ME; Epstein J; Dodd RY; Persing D; Will RG; DeMaria A; Emmanuel JC; Pierce B; Khabbaz R
    Emerg Infect Dis; 1998; 4(3):410-1. PubMed ID: 9716958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.